| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Thursday - Jan 13, 2011 |
|||||||||
| Q4 FY10 | $0.59 | $0.53 | $11.46B | $10.29B |
NASDAQ |
||||
|
MSCI
MSCI
|
- | $0.36 | $0.36 | $202.73M | $213.32M |
NYSE |
|||
|
Washington Federal
WAFD
|
- | $0.22 | $0.22 | $109.16M | $109.10M |
NASDAQ |
|||
|
CRA International
CRAI
|
- | $0.35 | $0.31 | $75.86M | $67.23M |
NASDAQ |
|||
|
Aehr Test Systems
AEHR
|
- | -$0.09 | - | $3.58M | - |
NASDAQ |
|||
|
ABVC BioPharma
ABVC
|
- | -$133.80 | - | $2.47K | - |
NASDAQ |
|||
|
Oramed Pharmaceuticals
ORMP
|
- | -$0.12 | - | - | - |
NASDAQ |
|||
|
Aytu BioPharma
AYTU
|
- | -$2.95 K | - | - | - |
NASDAQ |
|||
